Journal Title：Lancet Rheumatology

The Lancet Rheumatology is an independent journal committed to publishing content relevant to rheumatology specialists worldwide, with a focus on studies that advance clinical practice, challenge the status quo, and advocate change in health policy. The journal publishes clinical research (with a focus on clinical trials), expert reviews, and provocative comment and opinion relating to the diagnosis and classification, management, and prevention of rheumatic diseases, including arthritic, musculoskeletal, and connective tissue diseases, as well as disorders of the immune system. The journal also publishes high-quality human translational studies that are supported by robust clinical data, with priority given to studies that identify potential new therapeutic targets, advance efforts toward precision medicine, or have the potential to directly inform future clinical trials.

With a strong clinical focus, The Lancet Rheumatology provides an independent voice for the rheumatology community and advocates strongly for the improved lives of patients with rheumatic diseases around the globe.

《柳葉刀風濕病學》是一本獨立雜志，致力于發表與全球風濕病學專家相關的內容，重點關注推動臨床實踐、挑戰現狀和倡導衛生政策變革的研究。該雜志發表臨床研究（重點是臨床試驗）、專家評論以及與風濕病（包括關節炎、肌肉骨骼和結締組織疾病以及免疫系統疾病）的診斷和分類、管理和預防有關的發人深省的評論和意見。該雜志還發表由可靠臨床數據支持的高質量人類轉化研究，優先考慮確定潛在新治療目標、推動精準醫療努力或有可能直接為未來臨床試驗提供信息的研究。

《柳葉刀風濕病學》以臨床為重點，為風濕病學界提供了獨立的聲音，并大力倡導改善全球風濕病患者的生活。

Lancet Rheumatology由ELSEVIER出版商出版，收稿方向涵蓋RHEUMATOLOGY全領域，在行業領域中學術影響力很大，屬于國際一流期刊，關注度和專業度非常高，所以對原創文章要求創新性很高，過審難度很高，如果您有志于一流期刊，建議關注此刊。平均審稿速度 ，影響因子指數15，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。